Anthem Inc (ANTM) Receives a Buy from Barclays

By Ryan Adsit

In a report issued on January 4, Steven Valiquette from Barclays maintained a Buy rating on Anthem Inc (ANTMResearch Report), with a price target of $282. The company’s shares closed on Friday at $249.91.

According to, Valiquette is a 4-star analyst with an average return of 4.1% and a 48.2% success rate. Valiquette covers the Services sector, focusing on stocks such as AmerisourceBergen Corporation, Patterson Companies Inc, and WellCare Health Plans.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Anthem Inc with a $319.33 average price target, a 27.8% upside from current levels. In a report issued on January 3, Evercore ISI also upgraded the stock to Buy.


See today’s analyst top recommended stocks >>

The company has a one-year high of $300.57 and a one-year low of $215.52. Currently, Anthem Inc has an average volume of 1.56M.

Based on the recent corporate insider activity of 15 insiders, corporate insider sentiment is negative on the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Anthem, Inc. provides life, hospital and medical insurance plans. It offers a broad spectrum of network-based managed care health benefit plans to the large and small employer, individual, Medicaid, and Medicare markets. The company operates through two segments: Commercial & Specialty Business, Government Business and Other.